Company / Depreciation & Amortization
Gossamer Bio, Inc. Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$24.0K
FY2025
5-year range
$24.0K / $1.8M
FY2021-FY2025
Trend
-97.1%
vs FY2024
Sector context
#167 of 168
Health Care
What the data says
Among 168 Health Care companies, Gossamer Bio, Inc. is in the top 1% for depreciation & amortization. Depreciation & Amortization has declined for 3 consecutive years, from $2M in FY2022 to $24,000 in FY2025.
Based on SEC 10-K filings.
$24,000 in FY2025 with a 5-year CAGR of -55.7%.
Improved from $2M to $24,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -76.4%
- 5-Year CAGR
- -55.7%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 168This company $24.0K Sector average $212.9M
▼
-100.0% below sector average
Key checks
Key Insights
- Gossamer Bio, Inc.'s depreciation & amortization has declined for 3 consecutive years.
- 5-year CAGR of -55.7%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 97.1% year-over-year.
- Ranks #167 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.0K | -97.1% |
| FY2024 | $833.0K | -48.2% |
| FY2023 | $1.6M | -12.3% |
| FY2022 | $1.8M | +5.3% |
| FY2021 | $1.7M | +23.5% |
| FY2020 | $1.4M | +53.7% |
| FY2019 | $917.0K | +208.8% |
| FY2018 | $297.0K | - |
| FY2017 | $0 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026